Department of Urology Divisions | NYU Langone Health

Skip to Main Content

Department of Urology Divisions

Our divisions reflect the range of subspecialities in urology.

The six divisions in NYU Langone’s Department of Urology represent the depth of our faculty members’ expertise and the breadth of the field.

Division of Endourology

Faculty in NYU Langone’s Division of Endourology, led by Philip T. Zhao, MD, diagnose and provide medical and surgical treatments for ureteral strictures and stone diseases of the kidneys, ureter, and bladder, using minimally invasive techniques. Our experts have access to the most advanced urinary tract and renal imaging in the country and perform highly advanced and complex stone procedures, including percutaneous nephrolithotomy.

Our division members are leaders in the research of device efficacy. NYU Langone serves as a validation site for all major endourology devices, providing our doctors and trainees with experience in the newest technologies.

In addition to Dr. Zhao, our division members are James Borin, MD, and Mark Silva, MD.

Division of Female Pelvic Medicine, Reconstructive Surgery, and Neurourology

Led by Benjamin M. Brucker, MD, the Division of Female Pelvic Medicine, Reconstructive Surgery, and Neurourology is dedicated to advancing the practice and science of surgical treatment of pelvic floor and neurological voiding disorders. At NYU Langone’s Center for Female Pelvic Medicine we provide compassionate care using advanced techniques and our extensive experience.

Our team has unique expertise in complicated vaginal and reconstructive surgery using advanced laparoscopic and robotic approaches. In addition to pelvic organ prolapse, incontinence, and complications from obstetric injury or gynecologic surgery, our team also treats conditions that affect the lower urinary tract such as overactive bladder, urethral stricture, and mesh-related complications.

We also have world-renowned expertise in the evaluation and treatment of bladder conditions caused or exacerbated by multiple sclerosis, Parkinson’s disease, and stroke or spinal cord pathology. People with these conditions have access to thorough diagnostics and advanced treatments at NYU Langone.

Although our division is considered one of the best in the nation, we continue to improve all aspects of care, from patient experience to the science and understanding of the conditions that affect women. We also continually work to perfect both conservative behavioral treatments and medical therapies as well as surgical techniques, enabling us to offer highly personalized care.

In addition to Dr. Brucker, members of our division are Nirit Rosenblum, MD and Lauren E. Stewart, MD.

To help train future leaders in our field, NYU Grossman School of Medicine offers the Female Pelvic Medicine and Reconstructive Surgery Fellowship through our division.

Division of Gender-Affirming and Urologic Reconstructive Surgery

Led by Lee C. Zhao, MD, director of male reconstructive surgery and co-director of transgender reconstructive surgery, the Division of Gender-Affirming and Urologic Reconstructive Surgery is a collaboration with NYU Langone’s Hansjörg Wyss Department of Plastic Surgery. NYU Langone is a leader in transgender surgery services.

Division of Male Sexual Medicine and Benign Conditions of the Prostate

In the Division of Male Sexual Medicine and Benign Conditions of the Prostate, led by Bobby B. Najari, MD, our faculty diagnose and treat men’s sexual health problems including erectile dysfunction, Peyronie’s disease, premature ejaculation, and hypogonadism.

Research in our division includes a focus on the use of high-quality nationally representative data to address areas that are challenging to evaluate in the standard healthcare setting. For instance, using the National Survey for Family Growth, we have helped characterize the demographics of infertile men who lack access to fertility treatments and evaluated the association of male infertility with a man’s overall health status. An additional focus is evaluating the impact of the economy on vasectomy utilization and reviewing the safety of performing vasectomy in men without children. In addition to Dr. Najari, our faculty members are Seth D. Cohen, MD, MPH, Christopher E. Kelly, MD, Jeffrey A. Lessing, MD, and Thomas Spears, MD.

Division of Pediatric Urology

Urologic diseases of childhood require specialized diagnostic equipment, procedures, and surgical management. The Division of Pediatric Urology is led by Ellen Shapiro, MD, chief of pediatric urology at Tisch Hospital, Kimmel Pavilion, and NYC Health + Hospitals/Bellevue, and Grace S. Hyun, MD, chief of pediatric urology at NYU Langone Hospital—Brooklyn. Our division has developed a comprehensive specialty program that addresses the unique needs of infants, children, and adolescents.

Our faculty bring together more than 40 years of experience in caring exclusively for pediatric urological disorders such as hernias, hypospadias, neurogenic bladder, prenatally diagnosed hydronephrosis, undescended testes, urinary stone disease, vaginal abnormalities, varicoceles, vesicoureteral reflux, and many other conditions. We perform complex reconstructions for patients with neurogenic bladder, exstrophy of the bladder, and other rare congenital anomalies. We also perform the Malone antegrade continence enema (MACE) procedure for patients with chronic neurological bowel dysfunction.

Dr. Shapiro and Dr. Hyun work closely with specialists in maternal–fetal medicine, providing prenatal counseling to expectant parents. Pediatric radiologists, pediatric anesthesiologists, and other pediatric specialists at NYU Langone and NYU Langone Hospital—Brooklyn collaborate to provide exceptional pediatric-centered urologic care. The most advanced sonographic evaluation is available in our office to expedite the care and treatment of children in a patient-friendly setting. In addition, we perform highly specialized videourodynamic evaluations to assist in formulating medical and surgical management of complex bladder conditions.

Dr. Shapiro’s research over the past 30 years has focused on the embryology of the human lower urinary tract using detailed histological and three-dimensional reconstructive techniques. Her findings have furthered our understanding of common and complex pediatric urological anomalies. More recently, our urology research labs have focused on the effect of the microbiome on urinary tract infection and stone formation.

Dr. Shapiro and Dr. Hyun work directly with medical students in our pediatric urology clinic. In addition to one-on-one teaching with each student during their pediatric rotation, we provide students with the opportunity to learn physical genitourinary examination of pediatric patients in a well-supervised setting. We can also arrange for medical student participation in the operating room on request.

Division of Urologic Oncology

The Division of Urologic Oncology, led by division director Samir S. Taneja, MD, is comprised of 10 urologic surgeons focused on management of cancers arising from the prostate, kidneys, bladder, urinary tract, and male genitals. Our surgeons are internationally renowned and have vast expertise in techniques of minimally invasive and conventional surgery. We are innovators in the field of prostate imaging, MRI-targeted biopsy, focal ablative treatments for prostate cancer, and robotics-assisted surgical applications in urologic oncology.

Our faculty are fully integrated within the Genitourinary Cancer Disease Management Group of NYU Langone’s Perlmutter Cancer Center and collaborate with medical and radiation oncologists through weekly conferences and daily patient care. The division’s research includes a broad and diverse portfolio consisting of clinical studies, medical device development, translational and laboratory research, health services research, and clinical trials in diagnosis and therapies.

In addition to Dr. Taneja, members of our division are Mohit Gupta, MD, Herbert Lepor, MD, Stacy Loeb, MD, MSc, William C. Huang, MD, Danil V. Makarov, MD, Richard S. Matulewicz, MD, Gary D. Steinberg, MD, and James S. Wysock, MD.